Skip to main content

Advertisement

SpringerLink
Log in

Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The association of chronic migraine (CM) with an idiopathic intracranial hypertension without papilledema (IIHWOP), although much more prevalent than expected in clinical series of CM sufferers, is not included among the risk factors for migraine progression. We discuss the available evidence supporting the existence of a pathogenetic link between CM and idiopathic intracranial hypertensive disorders and suggest a causative role for IIHWOP in migraine progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bigal ME, Lipton RB (2008) Concepts and mechanisms of migraine chronification. Headache 48:7–15

    Article  PubMed  Google Scholar 

  2. Bigal ME, Lipton RB (2008) Clinical course in migraine conceptualizing migraine transformation. Neurology 71:848–855

    Article  PubMed  Google Scholar 

  3. Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27:102–106

    Article  CAS  PubMed  Google Scholar 

  4. Mathew NT (1993) Transformed migraine. Cephalalgia 13:78–83

    PubMed  Google Scholar 

  5. Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset remission of chronic daily headache in a population-based study. Pain 106:81–89

    Article  CAS  PubMed  Google Scholar 

  6. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2005) Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 65:1556–1561

    Article  CAS  PubMed  Google Scholar 

  7. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 (Suppl 1):9–160

  8. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB (2004) Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 44:684–691

    Article  PubMed  Google Scholar 

  9. Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746

    Article  Google Scholar 

  10. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB (2007) The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia 27:230–234

    Article  Google Scholar 

  11. Sancisi E, Cevoli S, Pierangeli G, Zanigni S, Grimaldi D, Nicodemo M, Cortelli P, Montagna P (2007) Application of ICHD-II and revised diagnostic criteria to patients with chronic daily headache. Neurol Sci 28:2–8

    Article  CAS  PubMed  Google Scholar 

  12. D’Amico D, Tullo V, Proietti Cecchini A, Usai S, Mea E, Bussone G (2008) Application of revised criteria for chronic migraine and medication overuse headache in a tertiary headache centre. Neurol Sci 29:S158–S160

    Article  PubMed  Google Scholar 

  13. Siberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 34:1–7

    CAS  PubMed  Google Scholar 

  14. Scher AI, Stewart WF, Liberman J, Lipton RB (1998) Prevalence of frequent headache in a population sample. Headache 38:497–506

    Article  CAS  PubMed  Google Scholar 

  15. Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s classification of functioning, disability and health (ICF). J Headache Pain 6:429–440

    Article  PubMed  Google Scholar 

  16. Edmeads J, Mackell JA (2002) The economic impact of migraine: an analysis of direct and indirect costs. Headache 42:501–509

    Article  PubMed  Google Scholar 

  17. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J et al (2009) Economic burden of transformed migraine: results from the American migraine prevalence and prevention (AMPP) study. Headache 49:498–508

    Article  PubMed  Google Scholar 

  18. Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G et al (2008) Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache 48:1087–1095

    Article  PubMed  Google Scholar 

  19. Bigal ME, Lipton RB (2009) What predicts the change from episodic to chronic migraine? Curr Opin Neurol 22:269–276

    Article  PubMed  Google Scholar 

  20. Zeeberg P, Olesen J, Jensen R (2006) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66:1894–1898

    Article  PubMed  Google Scholar 

  21. Zeeberg P, Olesen J, Jensen R (2006) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26:1192–1198

    Article  CAS  PubMed  Google Scholar 

  22. Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43:179–190

    Article  PubMed  Google Scholar 

  23. Castillo J, Munoz P, Guitera V, Pascual J (1999) Kaplan Award 1998: epidemiology of chronic daily headache in the general population. Headache 39:190–196

    Article  CAS  PubMed  Google Scholar 

  24. Colás R, Muñoz P, Temprano R, Gómez C, Pascual J (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62:1338–1342

    PubMed  Google Scholar 

  25. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871–875

    CAS  PubMed  Google Scholar 

  26. Obermann M, Nyhuis P et al (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26:1106–1114

    Article  PubMed  Google Scholar 

  27. Friedman DI, Jacobson DM (2002) Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59:1492–1495

    Article  PubMed  Google Scholar 

  28. Lipton HL, Michelson PE (1972) Pseudotumor cerebri syndrome without papilledema. J Am Med Assoc 220:1591–1592

    Article  CAS  Google Scholar 

  29. Marcelis J, Silberstein SD (1992) Idiopathic intracranial hypertension without papilledema. Arch Neurol 48:392–399

    Google Scholar 

  30. Farb RI, Vanek I, Scott JN, Mikulis DJ, Willinsky RA, Tomlinson G, terBrugge KG (2003) Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 60:1418–1424

    CAS  PubMed  Google Scholar 

  31. King JO, Mitchell PJ, Thomson KR, Tress BM (2002) Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 58:26–30

    CAS  PubMed  Google Scholar 

  32. Karakalios DG, Rekate HL, Khayata MH, Apostolides PJ (1996) Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 46:198–202

    Google Scholar 

  33. De Simone R, Marano E, Fiorillo C, Briganti F, Di Salle F, Volpe A, Bonavita V (2005) Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension: pathogenetic implications. Neurol Sci 25:342–344

    Article  PubMed  Google Scholar 

  34. Higgins JNP, Pickard JD (2004) Lateral sinus stenosis in idiopathic intracranial hypertension resolving after CSF diversion. Neurology 62:1907–1908

    PubMed  Google Scholar 

  35. Baryshnik DB, Farb RI (2004) Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 62:1445–1446

    PubMed  Google Scholar 

  36. Rohr A, Dörner L, Stingele R, Buhl R, Alfke K, Jansen O (2007) Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol 28:656

    CAS  PubMed  Google Scholar 

  37. Brazis PW (2008) Clinical review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 28:1361–1373

    Article  CAS  PubMed  Google Scholar 

  38. Stevens SA, Lakin W, Thakore N, Penar PL, Tranmer B (2005) A modeling study of idiopathic intracranial hypertension. In: Ursino M (ed) Modelling in medicine and biology VI, WIT Press, Southampton

  39. Stevens SA, Stimpson J, Lakin WD, Thakore NJ, Penar PL (2008) A model for idiopathic intracranial hypertension and associated pathological ICP wave-forms. IEEE Trans Biomed Eng 55(2 Pt 1):388–398

    Article  PubMed  Google Scholar 

  40. Bono F, Giliberto C, Mastrandrea C, Cristiano D, Lavano A, Fera F, Quattrone A (2005) Transverse sinus stenosis persist after normalization of the CSF pressure in IIH. Neurology 65:1090–1093

    Article  CAS  PubMed  Google Scholar 

  41. Torbey MT, Geocadin RG, Razumovsky AY, Rigamonti D, Williams MA (2003) Utility of CSF pressure monitoring to identify idiopathic intracranial hypertension without papilledema in patients with chronic daily headache. Cephalalgia 24:495–502

    Article  Google Scholar 

  42. Bono F, Messina D, Giliberto C, Cristiano D, Broussard G, D’Asero S, Condino F, Mangone L, Mastrandrea C, Fera F, Quattrone A (2008) Bilateral transverse sinus stenosis and idiopathic intracranial hypertension without papilledema in chronic tension-type headache. J Neurol 255(6):807–812

    Article  CAS  PubMed  Google Scholar 

  43. Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46:1226–1230

    CAS  PubMed  Google Scholar 

  44. Wang SJ, Silberstein SD, Patterson S, Young WB (1998) Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology 51(1):245–249

    CAS  PubMed  Google Scholar 

  45. Vieira DS, Masruha MR, Gonçalves AL, Zukerman E, Senne Soares CA, Naffah-Mazzacoratti Mda G, Peres MF (2008) Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 28:609–613

    Article  CAS  PubMed  Google Scholar 

  46. Bono F, Quattrone A (2009) Idiopathic intracranial hypertension without papilloedema in headache sufferers. Cephalalgia 29(5):593 (author reply 594)

    Google Scholar 

  47. Bono F, Messina D, Giliberto C, Cristiano D, Broussard G, Fera F et al (2006) Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 67:419–423

    Article  CAS  PubMed  Google Scholar 

  48. Wall M (2008) Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 8:87–93

    Article  PubMed  Google Scholar 

  49. Marcus DM, Lynn J, Miller JJ, Chaudhary O, Thomas D, Chaudhary B (2001) Sleep disorders: a risk factor for pseudotumor cerebri? J Neuroophthalmol 21:121–123

    CAS  PubMed  Google Scholar 

  50. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ et al (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814–823

    Article  PubMed  Google Scholar 

  51. Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29:1021–1027

    Article  PubMed  Google Scholar 

  52. Dodgson SJ, Shank RP, Maryanoff BE (2000) Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia 41(Suppl 1):S35–S39

    Article  CAS  PubMed  Google Scholar 

  53. Johnson LN, Krohel GB, Madsen RW, March GA Jr (1998) The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105:2313–2317

    Article  CAS  PubMed  Google Scholar 

  54. Pagan FL, Restrepo L, Balish M, Patwa HS, Houff S (2002) A new drug for an old condition. Headache 42:695–696

    Article  PubMed  Google Scholar 

  55. Palacio E, Rodero L, Pascual J (2004) Topiramate-responsive headache due to idiopathic intracranial hypertension in Behcet syndrome. Headache 44:436–437

    Article  PubMed  Google Scholar 

  56. Celebisoy N, Gökçay F, Sirin H, Akyürekli O (2007) Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 116:322–327

    Article  CAS  PubMed  Google Scholar 

  57. De Simone R, Marano E, Bilo L, Briganti F, Esposito M, Ripa P et al (2006) Idiopathic intracranial hypertension without headache. Cephalalgia 26:1020–1021

    Article  PubMed  Google Scholar 

  58. Bonavita V, De Simone R (2008) Towards a definition of comorbidity in the light of clinical complexity. Neurol Sci 29(Suppl 1):S99–S102

    Article  PubMed  Google Scholar 

  59. Doepp F, Schreiber SJ, Dreier JP, Einhäupl KM, Valdueza JM (2003) Migraine aggravation caused by cephalic venous congestion. Headache 43:96–98

    Article  PubMed  Google Scholar 

  60. Chou CH, Chao AC, Lu SR, Hu HH, Wang SJ (2004) Cephalic venous congestion aggravates only migraine-type headaches. Cephalalgia 24:973–979

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache Centre, Department of Neurological Sciences, University of Naples “Federico II”, via Pansini, 5, 80131, Naples, Italy

    Roberto De Simone, Angelo Ranieri & Leonilda Bilo

  2. Istituto Di Diagnosi e Cura Hermitage Capodimonte, Naples, Italy

    Chiara Fiorillo & Vincenzo Bonavita

Authors
  1. Roberto De Simone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelo Ranieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chiara Fiorillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leonilda Bilo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincenzo Bonavita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto De Simone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Simone, R., Ranieri, A., Fiorillo, C. et al. Is idiopathic intracranial hypertension without papilledema a risk factor for migraine progression?. Neurol Sci 31, 411–415 (2010). https://doi.org/10.1007/s10072-010-0229-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-010-0229-1

Keywords

Search

Navigation